Found: 7
Select item for more details and to access through your institution.
N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma Cells.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6044, doi. 10.3390/cancers14246044
- By:
- Publication type:
- Article
Anti‐viral innate immunity: Is it where type 1 diabetes really begins?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 5, p. 1, doi. 10.1002/dmrr.3623
- By:
- Publication type:
- Article
N6‐isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity.
- Published in:
- FEBS Open Bio, 2024, v. 14, n. 5, p. 843, doi. 10.1002/2211-5463.13766
- By:
- Publication type:
- Article
Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1202, doi. 10.3390/diagnostics11071202
- By:
- Publication type:
- Article
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children.
- Published in:
- Diabetologia, 2024, v. 67, n. 4, p. 714, doi. 10.1007/s00125-023-06075-3
- By:
- Publication type:
- Article
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
- Published in:
- Diabetologia, 2023, v. 66, n. 1, p. 132, doi. 10.1007/s00125-022-05812-4
- By:
- Publication type:
- Article
High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease.
- Published in:
- Diabetologia, 2022, v. 65, n. 8, p. 1390, doi. 10.1007/s00125-022-05724-3
- By:
- Publication type:
- Article